RNA therapeutics
E621880
RNA therapeutics are medical treatments that use RNA molecules to modulate gene expression or protein production for preventing, treating, or curing disease.
All labels observed (1)
| Label | Occurrences |
|---|---|
| RNA therapeutics canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T6831384 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: RNA therapeutics Context triple: [Drew Weissman, hasResearchInterest, RNA therapeutics]
-
A.
mRNA vaccine
An mRNA vaccine is a type of vaccine that uses a small piece of messenger RNA to instruct cells to produce a viral protein, triggering an immune response without using a live virus.
-
B.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
C.
DRNA
DRNA is the commonly used acronym for Puerto Rico’s Department of Natural and Environmental Resources, the government agency responsible for managing and protecting the island’s natural resources and environment.
-
D.
Molecules and Medicine
Molecules and Medicine is a book that explores the chemical structures, design, and mechanisms of important pharmaceutical drugs and their impact on human health.
-
E.
CRISPR-Cas9 gene-editing technology
CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: RNA therapeutics Target entity description: RNA therapeutics are medical treatments that use RNA molecules to modulate gene expression or protein production for preventing, treating, or curing disease.
-
A.
mRNA vaccine
An mRNA vaccine is a type of vaccine that uses a small piece of messenger RNA to instruct cells to produce a viral protein, triggering an immune response without using a live virus.
-
B.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
C.
DRNA
DRNA is the commonly used acronym for Puerto Rico’s Department of Natural and Environmental Resources, the government agency responsible for managing and protecting the island’s natural resources and environment.
-
D.
Molecules and Medicine
Molecules and Medicine is a book that explores the chemical structures, design, and mechanisms of important pharmaceutical drugs and their impact on human health.
-
E.
CRISPR-Cas9 gene-editing technology
CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
- F. None of above. chosen
Statements (52)
| Predicate | Object |
|---|---|
| instanceOf |
biomedical technology
ⓘ
molecular medicine approach ⓘ therapeutic modality ⓘ |
| aimsTo |
cure disease
ⓘ
prevent disease ⓘ treat disease ⓘ |
| commonlyUses |
conjugate delivery systems
ⓘ
lipid nanoparticles ⓘ polymeric nanoparticles ⓘ |
| enables |
personalized medicine
ⓘ
rapid vaccine development ⓘ |
| facesChallenge |
RNA instability
ⓘ
immune activation ⓘ off-target effects ⓘ targeted delivery ⓘ |
| includesSubtype |
RNA aptamer therapeutics
ⓘ
RNA vaccine ⓘ antisense oligonucleotide therapeutics ⓘ guide RNA-based genome editing therapeutics ⓘ mRNA therapeutics ⓘ miRNA therapeutics ⓘ self-amplifying RNA therapeutics ⓘ siRNA therapeutics ⓘ |
| isFieldOf |
drug development
ⓘ
translational research ⓘ |
| mechanismOfAction |
gene silencing
ⓘ
gene upregulation ⓘ protein replacement ⓘ receptor binding ⓘ splicing modulation ⓘ translation inhibition ⓘ |
| regulatoryApprovedExample |
COVID-19 mRNA vaccines
ⓘ
eteplirsen NERFINISHED ⓘ givosiran NERFINISHED ⓘ inclisiran NERFINISHED ⓘ inotersen NERFINISHED ⓘ mipomersen NERFINISHED ⓘ nusinersen NERFINISHED ⓘ patisiran NERFINISHED ⓘ |
| requires | delivery system ⓘ |
| targetsProcess |
gene expression
ⓘ
protein production ⓘ |
| treats |
cancer
ⓘ
genetic diseases ⓘ infectious diseases ⓘ metabolic disorders ⓘ neurological disorders ⓘ |
| usesMoleculeType | RNA ⓘ |
| usesStrategy |
chemical modification of nucleotides
ⓘ
codon optimization ⓘ formulation optimization ⓘ sequence optimization ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: RNA therapeutics Description of subject: RNA therapeutics are medical treatments that use RNA molecules to modulate gene expression or protein production for preventing, treating, or curing disease.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.